SOLID TUMOR MALIGNANCY

Clinical trials for SOLID TUMOR MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMOR MALIGNANCY trials appear

Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 4 Completed 1 Terminated 1

Targeted drug pemigatinib tested in tumors with FGFR mutations – trial stopped early

Disease control Terminated

This phase 2 study tested the drug pemigatinib in 111 people with advanced solid tumors that have specific FGFR gene mutations or translocations. The goal was to see if the drug could shrink tumors. The trial was terminated early, so the full results are not available.

Matched conditions: SOLID TUMOR MALIGNANCY

Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

SOLID TUMOR MALIGNANCY

Get alerted when new SOLID TUMOR MALIGNANCY trials appear

Targeted drug pemigatinib tested in tumors with FGFR mutations – trial stopped early